STAAR Surgical (STAA) CDO awarded 33,838 RSUs and boosts holdings

Rhea-AI Filing Summary

STAAR Surgical’s Chief Development Officer Magda Michna reported several equity compensation events. On March 13, 2026, she received a grant of 33,838 restricted stock units (RSUs), which are scheduled to vest in three equal tranches in 2027, 2028, and 2029.

On March 12 and 14, 2026, previously granted RSUs vested and were converted into a total of 23,773 shares of common stock. In connection with these vestings, the company withheld 2,216 shares at $18.39 and 6,313 shares at $18.84 to cover tax obligations, which is recorded as a disposition but not an open‑market sale. Following these transactions, Michna directly holds 29,668 shares of common stock, along with RSUs that remain subject to future vesting.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Michna Magda

(Last) (First) (Middle)

25510 COMMERCENTRE DRIVE

(Street)

LAKE FOREST CA 92630

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Development Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/12/2026		M		6,178(1)	A	$0	20,622	D
Common Stock	03/12/2026		F		2,216(1)	D	$18.39	18,406	D
Common Stock	03/14/2026		M		14,663(3)	A	$0	33,069	D
Common Stock	03/14/2026		M		2,932(4)	A	$0	36,001	D
Common Stock	03/14/2026		F		6,313(3)(4)	D	$18.84	29,668(5)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(6)	03/12/2026		M			6,178	(1)	(1)	Common Stock	6,178	$0	6,178	D
Restricted Stock Units	$0(6)	03/13/2026		A		33,838		(2)	(2)	Common Stock	33,838	$0	33,838	D
Restricted Stock Units	$0(6)	03/14/2026		M			14,663	(3)	(3)	Common Stock	14,663	$0	29,326	D
Restricted Stock Units	$0(6)	03/14/2026		M			2,932	(4)	(4)	Common Stock	2,932	$0	5,866	D

Explanation of Responses:

1. Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (6,177 shares) on March 12, 2025, 1/3 (6,178 shares) on March 12, 2026, and will vest as to 1/3 (6,178 shares) on March 12, 2027. On March 12, 2026, 2,216 shares were witheld upon vesting to satisfy taxes.

2. Reflects RSUs granted to the Reporting Person on March 13, 2026 in connection with annual equity award. These RSUs vest as to 1/3 (11,279 shares) on March 13, 2027, 1/3 (11,279 shares) on March 13, 2028, and 1/3 (11,280 shares) on March 13, 2029.

3. Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (14,663 shares) on March 14, 2026, and will vest as to 1/3 (14,663 shares) on March 14, 2027, and 1/3 (14,663 shares) on March 14, 2028. On March 14, 2026, 5,261 shares were witheld upon vesting to satisfy taxes.

4. Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (2,932 shares) on March 14, 2026, and will vest as to 1/3 (2,933 shares) on March 14, 2027, and 1/3 (2,933 shares) on March 14, 2028. On March 14, 2026, 1,052 shares were witheld upon vesting to satisfy taxes.

5. Includes previously granted RSUs, which are subject to future vesting.

6. Each RSU represents the right to receive one share of the Corporation's common stock upon vesting.

	/s/ Magda Michna	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider equity transactions did STAA’s Magda Michna report on this Form 4?

Magda Michna reported RSU grants, vesting, exercises, and tax withholdings. She received a new 33,838 RSU award and had multiple earlier RSU grants vest and convert into common stock, with some shares withheld to satisfy tax obligations rather than sold on the market.

How many restricted stock units did STAA grant to Magda Michna in March 2026?

She was granted 33,838 restricted stock units on March 13, 2026. According to the disclosure, these RSUs vest one‑third, or 11,279 shares, in 2027 and 2028, and 11,280 shares in 2029, providing a multi‑year equity incentive tied to future service.

How many STAA shares did Magda Michna acquire through RSU vesting in March 2026?

Previously granted RSUs converted into 23,773 shares of common stock. These exercises occurred on March 12 and March 14, 2026, reflecting routine vesting of earlier awards rather than open‑market purchases, and increased her direct common stock ownership before tax‑related withholdings.

What STAA shares were withheld to cover Magda Michna’s tax obligations?

A total of 8,529 shares were withheld for taxes on vesting. The company withheld 2,216 shares at $18.39 on March 12, 2026, and 6,313 shares at $18.84 on March 14, 2026, which are recorded as F‑code tax‑withholding dispositions, not market sales.

How many STAAR Surgical common shares does Magda Michna hold after these transactions?

She holds 29,668 shares of common stock directly after the transactions. This figure reflects RSU conversions into common stock, net of shares withheld to satisfy tax liabilities, as reported in the final non‑derivative ownership line of the Form 4.

How do the new RSUs granted to STAA’s Magda Michna vest over time?

The 33,838 RSUs vest in three annual installments. The grant vests one‑third, or 11,279 shares, on March 13, 2027, another 11,279 shares on March 13, 2028, and the remaining 11,280 shares on March 13, 2029, aligning compensation with multi‑year performance.